Abstract
There has been renewed interest in the surgical treatment of Parkinson's disease (PD) over the past 20 years. In the 1940's to 1960's many PD patients underwent neurosurgical procedures to ablate specific brain targets to alleviate tremor and, to a lesser extent, akinesia and rigidity. With the introduction of levodopa in the 1960s, and the realization of its striking benefits, surgical treatment of movement disorders virtually disappeared. With time, limitations and adverse effects associated with drug treatment became all too apparent. With complications associated with long-term drug treatment, particularly levodopa-induced motor fluctuations and dyskinesias, limiting therapeutic effectiveness in many patients, surgery has been reexamined to address this unmet need. This has lead to the development and, now, widespread adoption of high-frequency deep brain stimulation (DBS). DBS has been shown to be a safe and effective treament for dopaminergic motor symptoms of PD, particularly tremor, rigidity, and bradykinesia, and has resulted in important reductions in motor complications of medical therapy. While DBS provides important symptomatic benefit, it does not appear to alter the natural history of PD. Other surgical strategies, including cellular transplantation and gene therapy aiming at neural repair and restoration, are currently being examined, but these have yet to be proven useful.
Keywords: Parkinsons disease, Deep brain stimulation, surgical treatment, VIM, Internal pulse generators, UPDRS, Hemiballismus, PPNa, Levodopa, Postcommissural putamen
CNS & Neurological Disorders - Drug Targets
Title: The Surgical Management of Parkinson's Disease
Volume: 10 Issue: 6
Author(s): Francisco A. Ponce and Andres M. Lozano
Affiliation:
Keywords: Parkinsons disease, Deep brain stimulation, surgical treatment, VIM, Internal pulse generators, UPDRS, Hemiballismus, PPNa, Levodopa, Postcommissural putamen
Abstract: There has been renewed interest in the surgical treatment of Parkinson's disease (PD) over the past 20 years. In the 1940's to 1960's many PD patients underwent neurosurgical procedures to ablate specific brain targets to alleviate tremor and, to a lesser extent, akinesia and rigidity. With the introduction of levodopa in the 1960s, and the realization of its striking benefits, surgical treatment of movement disorders virtually disappeared. With time, limitations and adverse effects associated with drug treatment became all too apparent. With complications associated with long-term drug treatment, particularly levodopa-induced motor fluctuations and dyskinesias, limiting therapeutic effectiveness in many patients, surgery has been reexamined to address this unmet need. This has lead to the development and, now, widespread adoption of high-frequency deep brain stimulation (DBS). DBS has been shown to be a safe and effective treament for dopaminergic motor symptoms of PD, particularly tremor, rigidity, and bradykinesia, and has resulted in important reductions in motor complications of medical therapy. While DBS provides important symptomatic benefit, it does not appear to alter the natural history of PD. Other surgical strategies, including cellular transplantation and gene therapy aiming at neural repair and restoration, are currently being examined, but these have yet to be proven useful.
Export Options
About this article
Cite this article as:
A. Ponce Francisco and M. Lozano Andres, The Surgical Management of Parkinson's Disease, CNS & Neurological Disorders - Drug Targets 2011; 10 (6) . https://dx.doi.org/10.2174/187152711797247795
DOI https://dx.doi.org/10.2174/187152711797247795 |
Print ISSN 1871-5273 |
Publisher Name Bentham Science Publisher |
Online ISSN 1996-3181 |
Call for Papers in Thematic Issues
Diagnosis and treatment of central nervous system infectious diseases
Infectious diseases of the central nervous system (CNS) can be divided into bacterial, tuberculous, viral, fungal, parasitic infections, etc. Early etiological treatment is often the most crucial means to reduce the mortality rate of patients with central nervous system infections, reduce complications and sequelae, and improve prognosis. The initial clinical ...read more
Techniques of Drug Repurposing: Delivering a new life to Herbs & Drugs
Of late, with the adaptation of innovative approaches and integration of advancements made towards medical sciences as well as the availability of a wide range of tools; several therapeutic challenges are being translated into viable clinical solutions, with a high degree of efficacy, safety, and selectivity. With a better understanding ...read more
Trends and perspectives in the rational management of CNS disorders
Central nervous system (CNS) diseases enforce a significant global health burden, driving ongoing efforts to improve our understanding and effectiveness of therapy. This issue investigates current advances in the discipline, focusing on the understanding as well as therapeutic handling of various CNS diseases. The issue covers a variety of diseases, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Functional Selectivity in GPCR Heterocomplexes
Mini-Reviews in Medicinal Chemistry Sleep in Pediatric Pulmonary Diseases
Current Respiratory Medicine Reviews Opiate Drug Use and the Pathophysiology of NeuroAIDS
Current HIV Research Laterality of Brain Activation for Risk Factors of Addiction
Current Drug Abuse Reviews Micropropagation: A Tool for the Production of High Quality Plant-based Medicines
Current Pharmaceutical Biotechnology Aminoglycoside-Induced Ototoxicity
Current Pharmaceutical Design Maternal Sodium Valproate Exposure Alters Neuroendocrine-Cytokines and Oxido-inflammatory Axes in Neonatal Albino Rats
Endocrine, Metabolic & Immune Disorders - Drug Targets Cellular, Molecular and Non-Pharmacological Therapeutic Advances for the Treatment of Parkinson's Disease: Separating Hope from Hype
Current Gene Therapy Synaptic Transmission at Functionally Identified Synapses in the Enteric Nervous System: Roles for Both Ionotropic and Metabotropic Receptors
Current Neuropharmacology Recent Patents on Biomedical Devices and Nanomaterials for Hyperthermal Therapy of Cancer
Recent Patents on Nanomedicine Current State of Development of Genome Analysis in Livestock
Current Genomics Concentration-Dependent Mechanisms of Adverse Drug Reactions in Epilepsy
Current Pharmaceutical Design AMPA Receptor Potentiators: Application for Depression and Parkinsons Disease
Current Drug Targets Bioactive Albumin-Based Carriers for Tumour Chemotherapy
Current Cancer Drug Targets A Two-layer Model to Identify Hepatitis B Virus Related Chronic Hepatitis and Liver Cirrhosis Based on Plasma microRNA Biomarkers
Combinatorial Chemistry & High Throughput Screening Effects of Palmitoylethanolamide and Luteolin in an Animal Model of Anxiety/Depression
CNS & Neurological Disorders - Drug Targets Disintegrins from Snake Venoms and their Applications in Cancer Research and Therapy
Current Protein & Peptide Science BOOK REVIEW : New Frontiers in Mirror Neurons Research
Current Aging Science Abnormal Head Posture due to Ocular Problems- A Review
Current Pediatric Reviews Patent Selections
Recent Patents on Mechanical Engineering